Published in Gene Therapy Weekly, November 15th, 2001
Patients with type 1 diabetes do not produce sufficient levels of insulin in pancreatic beta cells. Currently, several studies are looking at ways to stimulate insulin production by manipulating cell activity. A team at the University of Pennsylvania School of Medicine has designed a way to transfer the genes for human insulin into special cells of the pancreas called acinar cells. According to the researchers, they have obtained positive results using this new form of gene therapy in diabetic mice.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly